World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

(0) (0) (0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3568)

All Articles published online

Item

Count

PDF

136

HTML

1476

Figures (1-2)

432

Tables (1-3)

400

Sum=2444

Publishing Process of This Article

Item

Count

Browse

145

Download

831

Sum=976

Mar 24, 2025 (publication date) through May 20, 2026

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Wei ZJ, Wang L, Wang RQ, Wang Y, Chen H, Ma HL, Xu YJ. Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma. World J Clin Oncol 2025; 16(3): 101251 [PMID: 40130057 DOI: 10.5306/wjco.v16.i3.101251]
URL:	https://www.wjgnet.com/2218-4333/full/v16/i3/101251.htm

Number	Citing Articles
1	Wenxue Ma, Natalia Baran. Expanding horizons in esophageal squamous cell carcinoma: The promise of induction chemoimmunotherapy with radiotherapy. World Journal of Clinical Oncology 2025; 16(7): 104959 doi: 10.5306/wjco.v16.i7.104959 Abstract(215) \| Core Tip(209) \| Full Article(HTML)(814) \| Full Article with Cover (PDF)-737K(73) \| Audio-327K(18) \| Peer-Review Report-286K(56) \| Answering Reviewers-281K(54) \| Full Article (PDF)-484K(101) \| Full Article (XML)-241K(56) \| Times Cited (5) \| Total Visits (3080) \| Open
2	Kai Yang, Wei Shang, Lu Wang, Jianzhong He, Zhigang Zuo, Quankai Dai, Jialing Liu, Langhong Zeng, Yuntian Yang, Fengjun Cao, Yuandong Yu, Guoxing Wan. Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1784688
3	Xuefei Fan, Xin Liu, Song Mi, Yunxin Yang, Chenggong Li, Jiandong Zhang, Pingping Hu. Induction immunochemotherapy followed by concurrent chemoradiotherapy improves survival in unresectable esophageal cancer: a systematic review, meta-analysis, and network meta-analysis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1767380